Sulzer Medica gets rights to bone tissue product
This article was originally published in Clinica
Swiss company Sulzer Medica is to strengthen its spinal portfolio through a marketing and distribution agreement with Tutogen Medical for its Tutoplast human bone tissue products for spinal applications. Sulzer will pay $3 million over two years for the rights to the products, which address the $1 billion spinal fusion market. The two companies will also collaborate on the development of a range of proprietary tissue products and implants.